CORONA, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (Nasdaq:MNST) today revealed the findings of a group of physicians and a coroner that the company asked to examine the medical records of Anais Fournier, whose family filed a lawsuit blaming her death on the consumption of Monster Energy Drinks.
After the lawsuit was filed, even though Monster had every confidence in the safety of its products, the company retained a group of physicians, including a coroner, to independently ascertain whether there was any basis for the allegations in the suit. The company retained a cardiac pathologist, a cardiac electrophysiologist, an emergency room physician, a chief forensic pathologist/coroner, as well as other medical experts including a toxicologist and a pharmacologist.
"After an examination of Ms. Fournier's medical records, pathology report and autopsy report, the physicians stated conclusively that there is no medical, scientific or factual evidence to support the Maryland Medical Examiner's Report of 'caffeine toxicity' or that Ms. Fournier's consumption of two Monster Energy Drinks 24 hours apart contributed to, let alone was the cause of her untimely death," said Daniel Callahan, of Callahan & Blaine, one of Monster's lawyers."When the Maryland Medical Examiner was asked why her report contained the term 'caffeine toxicity,' she responded that it was because she had been told by Ms. Fournier's mother that Ms. Fournier had consumed an energy drink containing caffeine," Mr. Callahan said. "This was even though her report states that blood tests for caffeine levels were not done." "In fact, the physicians, including a coroner, we asked to examine Ms. Fournier's medical records and autopsy report found no medical, scientific or factual evidence to support a finding of caffeine toxicity," Mr. Callahan said. "They said no caffeine blood level test was performed to determine if any caffeine had been ingested. There is no medical or scientific evidence that Ms. Fournier had any caffeine in her system at the time of cardiac arrest."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts